ACLA In The News

  • ACLA Comments on PAMA Proposed Rule

    November 23, 2015
    ...
  • Reform the IOAS self-referral exception

    October 05, 2015
    ACLA and stakeholders ask Congress to support integrity in the practice of medicine and soften the blow to seniors by narrowing the IOAS exception, saving billions in Medicare and easing the pain of a Medicare Part B spike in premiums to certain seniors. Read more: https://thehill.com/blogs/congress-blog/healthcare/255696-reform-the-ioas-self-referral-exception  ...
  • National Men’s Health Week Provides Important Reminder of the Value of Diagnostic Testing In Disease Prevention

    June 15, 2015
    (Washington, D.C.) –  The American Clinical Laboratory Association (ACLA) today commemorates National Men’s Health Week (June 15-21, 2015) by encouraging men to stay informed about potential health risks, adopt healthy lifestyle patterns, stay tuned to disease symptoms and consult their physicians about diagnostic testing that could prevent disease onset and progression. “We know that some diseases discriminate and often greatly affect one gender andContinue Reading »...
  • Dark Daily: Obama’s $215 Million Precision Medicine Initiative: Will Congress Fund It and Can It Advance Genetic Testing and the Value of Clinical Laboratory Services?

    March 23, 2015
    Even as a new presidential initiative to boost precision medicine makes headlines, there is uncertainty as to how the program can be funded. The Precision Medicine Initiative was announced by President Obama on January 30, 2015. Many pathologists, clinical chemists, and medical laboratory scientists recognize that such a program would pump additional funds into the research and development of new diagnostic tests that areContinue Reading »...
  • Inside Health Policy: Clinical Lab Group Outlines Legal Arguments Against FDA’s LDT Oversight

    January 08, 2015
    The American Clinical Laboratory Association, the group heading up efforts to quash FDA’s planned oversight of laboratory developed tests (LDTs), released a white paper Wednesday (Jan. 7) blasting FDA’s proposed regulatory framework as “a dramatic overreach” without “any statutory basis.” The paper, authored by ACLA’s recently tapped counsel, Harvard University law professor Laurence Tribe and former Solicitor General Paul Clement, now a partner withContinue Reading »...
  • Roll Call Commentary: In Diagnostic Innovation, Something Incredible Is Waiting to Be Known

    September 15, 2014
    Astronomer, scientist and writer Carl Sagan is thought to have said, “Somewhere, something incredible is waiting to be known.” I know what that statement means because I live and breathe the reality of discovery every day, as do my colleagues practicing at nonprofit clinical laboratories in academic medical centers across the nation. We are engaged in scientific innovation that has improved the lives of countless patients. Congress hasContinue Reading »...
  • Senators Ask CMS to Put Changes To Doc Fee Codes in Proposed Rule

    June 24, 2014
    Bloomberg BNA June 23 — Twelve senators have asked the Centers for Medicare & Medicaid Services to place information on modifications of physician codes in the upcoming proposed Medicare Part B fee schedule, rather than just in the final rule. Placing “the results of CMS’s analysis and the rationale for any payment modifications” just in the final rule “limits the ability of providers to review the rationale and variousContinue Reading »...
  • Bloomberg BNA: Lab Industry Optimistic About New System Based on Private Pay Report Submissions

    April 25, 2014
    An upcoming market-based system for pricing services performed by clinical laboratories is a “better alternative” for the industry than the current Medicare payment system, the president of the American Clinical Laboratory Association said April 23. Although many questions remain to be answered, the system to align Medicare payment rates with the private sector will allow labs to avoid “multiple threats” to reimbursements, ACLA PresidentContinue Reading »...
  • ‘No rationale’ for Tricare’s refusal to cover genetic tests

    March 11, 2014
    A change in medical classifications last year has left clinical laboratories across the U.S. carrying a $10 million tab for Tricare. Tricare beneficiaries have not been billed for certain physician-ordered tests they have received at clinical laboratories since Jan. 1, 2013 — but Tricare also has not paid for them. At the heart of the standoff are genetic tests developed by laboratories that areContinue Reading »...
  • Innovation must be part of the cost evaluation of healthcare

    March 11, 2014
    Arguments can be made on both sides about access and quality, when comparing our healthcare system to the rest of the industrialized world. But, few would dispute that American healthcare is the most innovative in the world. In fact, the creativity and expertise of American manufacturers, doctors, hospitals and Academic Medical Centers, laboratories, drug companies, health IT companies, and other participants set the standardContinue Reading »...
1 2 3 4 5 6 7